Gro Østli Eilertsen
Job description
Førsteamanuensis. Spesialist i revmatologi. Forskningsgruppeleder, Revmatologi og Rehabilitering.
Thao,
Ingrid,
Morten,
Tom Eirik,
Ivana,
Mark W.
et al.:
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
Thao,
Morten,
Gia,
Gunnbjørg,
Ivana,
Mark W.
et al.:
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
Warren David,
Matthew,
Michael,
Gro Ostli,
Hans
:
Smoking associates with increased BAFF and decreased interferon-γlevels in patients with systemic lupus erythematosus
Sharma,
Warren David,
Gro Østli,
Hans
:
Association of Achieving Lupus Low Disease Activity State Fifty Percent of the Time With Both Reduced Damage Accrual and Mortality in Patients With Systemic Lupus Erythematosus
Warren David,
Gro Østli,
Sharanyaa,
Hans
:
The impact of cytokines on the health-related quality of life in patients with systemic lupus erythematosus
Seyed Esmaeil,
Aud-Malin Karlsson,
Premasany,
Gunnstein,
Gro Østli,
Stine
et al.:
Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis
Hege Lynum,
Kjersti Daae,
Dhivya,
Gudrun,
Natalya,
Gabriella
et al.:
Lupus nephritis: low urinary DNase I levels reflect loss of
renal DNase I and may be utilized as a biomarker of
disease progression
J,
Warren,
Gro Østli,
Hans
:
Insulin-like growth factor-1 (IGF1) in systemic lupus
erythematosus: relation to disease activity, organ damage
and immunological findings
Lupus 2018 DOI
Heather,
Warren David,
Gro Østli,
Johannes
:
The role of soluble erythropoietin receptors inanaemia of chronic disease in SLE and RA
International Journal of Rheumatic Diseases 06. septembre 2018 DOI
Heather,
Warren David,
Gro Østli,
Johannes
:
Soluble erythropoietin receptor levels
associate with inflammatory mediators
but not with disease activity or cumulative
organ damage in patients with systemic
lupus erythematosus
Warren David,
Gro Østli,
Johannes
:
Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
Cytokine 11. décembre 2018 DOI
Warren David,
Gro Østli,
Johannes
:
Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus
Warren D,
Gro Østli,
Sheynae,
Hans
:
IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.
European Journal of Rheumatology 2017 DOI
Michele,
Birgitta,
Søren,
Gro Østli,
Jan Åke,
Christian
et al.:
The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: An observational longitudinal study
Hans,
Warren D,
Gro Østli
:
Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation.
Lupus Science and Medicine 2016 DOI
Gro Østli,
Hans
:
APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus
Lupus 2014 DOI
Michele,
Ole Petter,
Anders,
Gunnar,
Niels H. H.,
Andreas
et al.:
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study
Michele,
S.,
Ole Petter,
L.,
Niels H. H.,
Johannes C
et al.:
Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study
Scandinavian Journal of Rheumatology 2013 DOI
Andrea,
Gro Østli,
S,
Johannes C
:
Circulating interferon-alpha 2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation
Lupus 2013 DOI
Gro Østli
:
Cytokiner ved SLE
BestPractice Norge 2012
Gro Østli,
Marijke Van,
Johannes C
:
BAFF expression is increased in Lupus Nephritis and associated with activation of C1 inhibitor, α-1-acid-glycoprotein and endothelial markers
Gro Østli,
Silje,
Tor-Arne,
Johannes C
:
Decreased incidence of lupus nephritis in northern Norway is linked to increased use of antihypertensive and anticoagulant therapy
Nephrology, Dialysis and Transplantation 2011 DOI
Gro Østli,
Marijke Van,
Harald,
Johannes C
:
Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study
Rheumatology 2011 DOI
Gro Østli,
Cathrin,
Andrea,
Johannes C
:
Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus
Lupus 2011 DOI
Gro Østli,
Silje,
Tor-Arne,
Johannes C
:
Decreased incidence of lupus nephritis in northern Norway is linked to increased use of antihypertensive and anticoagulant therapy
Nephrology, Dialysis and Transplantation 2010 DOI
Andrea,
Gro Østli,
Johannes C
:
Levels of Transforming Growth Factor-beta Are Low in Systemic Lupus Erythematosus Patients with Active Disease
Journal of Rheumatology 2010 DOI
Gro Østli,
Andrea,
Johannes C
:
The Influence of the 1997 Updated Classification Criteria for Systemic Lupus Erythematosus: Epidemiology, Disease Presentation, and Patient Management
Marija,
Elise Kiil,
Synne Elise,
Gro Østli
:
Differential Impact of Snuff versus Cigarette Use on Back and/or Pelvic Pain Among Psoriatic Arthritis Patients in Northern Norway
2024
Gro Østli
:
Lupus-syke Tu-Thao trodde hun skulle dø. En helt ny type behandling reddet livet hennes
Er dette en medisinsk revolusjon for pasienter med autoimmune sykdommer?
03. octobre 2024
Hege Lynum,
Kjersti Daae,
Dhivya,
Gudrun,
Natalya,
Gabriella
et al.:
LUPUS NEPHRITIS: SEVERELY REDUCED URINARY DNASE I LEVELS REFLECT LOSS OF RENAL DNASE I, DISEASE PROGRESSION AND MAY REDUCE THE NEED FOR RENAL BIOPSIES
2018
Chanakya,
Warren David,
Gro Østli,
Johannes
:
LUPUS LOW DISEASE ACTIVITY STATE (LLDAS-50) IS
A SIGNIFICANT PREDICTOR FOR DAMAGE ACCRUAL
AND MORTALITY: A NORWEGIAN COHORT ANALYSIS
Annals of the Rheumatic Diseases 12. juin 2018 DOI
Hans,
Warren,
Gro Østli
:
The functional state of Von Willebrand Factor is not increased in patients with Systemic Lupus Erythematosus.
2016
Gro Østli,
Lise
:
Infeksiøs endokarditt i Helse Nord
Senter for klinisk dokumentasjon og evaluering 2014
Gro Østli,
Iren Eide,
Ingunn M,
Johannes C
:
BAFF and APRIL activaion associate with different immunologic pathways in patients with SLR
2012
michele,
Søren,
Ole Petter,
Lennart,
Niels H. H.,
Johannes C
et al.:
Diagnostic Accuracy of Anti-dsDNA Antibodies in Unselected Patients with Recent Onset of Rheumatic Symptoms
Arthritis and Rheumatism 2012
Gro Østli,
Marijke van,
Harald,
Johannes C
:
Increased BAFF in Lupus Nephritis is unrelated to histological severity, but associates with acute-phase reactants and endothelial activation markers
2012
Gro Østli,
Johannes C
:
BAFF and APRIL activation is associated with different immunological pathways in patients with SLE
Scandinavian Journal of Rheumatology 2012
Gro Østli,
Johannes C
:
BAFF AND APRIL ACTIVATION ASSOCIATE WITH DIFFERENT IMMUNOLOGIC PATHWAYS IN PATIENTS WITH SLE
Scandinavian Journal of Rheumatology. Supplement 2012
Johannes C,
Maureen,
Sue,
Gro Østli
:
Increased BAFF levels in patients with SLE correlate with acute phase reactants independent of gene polymorphism or expression
2011
Gro Østli,
Marijke Van,
Harald,
Johannes C
:
INCREASED LEVELS OF BAFF IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS MIRROR ACUTE PHASE REACTANTS AND ARE INDEPENDENT OF BAFF PROMOTER GENOTYPE OR EXPRESSION IN PERIPHERAL BLOOD CELLS
Internal Medicine Journal 2011
Gro Østli
:
SLE-forskning BAFF og nyresykdom
Revmatikeren 2011
Gro Østli
:
Anti-CD22 - utprøving av et nytt medikament mot SLE
BestPractice 2011
Andrea,
Gro Østli,
Johannes C
:
LOW TRANSFORMING GROWTH FACTOR BETA LEVELS IN LUPUS PATIENTS WITH ACTIVE DISEASE
Scandinavian Journal of Rheumatology 2010
Gro Østli,
Marijke Van,
Harald,
Johannes C
:
B-cell activating factor levels correlate with acute phase reactants, but not with BAFF gene polymorphisms or BAFF gene expression in blood mononuclear cells in patients with Systemic Lupus Erythematosus: a case control study
2010
Gro Østli,
Marijke Van,
Harald,
Johannes C
:
CIRCULATING B-CELL ACTIVATING FACTOR IN PATIENTS WITH SLE CORRELATES WITH MARKERS OF INFLAMMATION BUT NOT WITH POLYMORPHISMS IN THE 5 ' REGULATORY REGION OF THE BAFF GENE OR MRNA EXPRESSION
Scandinavian Journal of Rheumatology. Supplement 2010
Gro Østli
:
Polymorfisme av BAFF-genet i relasjon til kliniske funn og autoantistoff ved sykddommen SLE
Revmatikeren 2008
Gro Østli,
Silje,
Tor-Arne,
Johannes C
:
Lupus Nephritis in Northern Norway: reduced prevalence and improved renal prognosis during the last decade
2008
Gro Østli,
Andrea,
kirsten synnØve,
Johannes C
:
Anti-C1q antibody production in SLE is a measure of anti-dsDNA and antinuclesome antibody mediated hypocomplementemia independent of B-lymphocyte activating factor and organ involvement
2008
Gro Østli,
Silje,
Tor-Arne,
Johannes C
:
Lupus Nephritis in Northern Norway: reduced prevalence and improved renal prognosis during the last decade
Lupus 2008
Gro Østli,
Andrea,
kirsten synnØve,
Johannes C
:
Anti-C1q antibody production in SLE is a measure of anti-dsDNA and antinuclesome antibody mediated hypocomplementemia independent of B-lymphocyte activating factor and organ involvement
Lupus 2008
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
Systemisk Lupus Erythematosus. Autoimmunitet. Revmatiske inflammatoriske sykdommer. Fatigue. Psoriasisartritt. Spondyloartritt.
Teaching
Revmatologi
Autoimmunitet
Member of research group
CV
2005, spesialist i revmatologi
2011, PhD: Clinical epidemiology of Systemic Lupus Erythematosus with emphasis on nephritis and autoantibody production